… The B-type Raf kinase (BRAF V600E) mutation in exon 15 of the BRAF gene has been … the
most prevalent form of thyroid cancer, papillary thyroid cancer (PTC)—a tumor type with high …

… the BRAF V600E mutation on long-term disease outcomes within an Australian cohort of
patients. The data suggest that patients with tumors containing BRAF V600E … with BRAF V600E -…

… , univariate pooled sensitivity using FNA and BRAF V600E results was 52% (95% … BRAF
V600E mutation analysis has a low sensitivity in diagnosing papillary thyroid cancer in thyroid …

… papillary thyroid cancer positive for the BRAF V600E … BRAF V600E mutation can be
detected in serum, an efficient diagnostic algorithm may be developed to diagnose thyroid cancer …

… we demonstrated that papillary thyroid carcinoma with BRAF V600E mutation was … the
incidence of BRAF V600E mutation in papillary microcarcinoma, and ask if the mutated tumors are …

… and 9,951 (39.4%) were tested negative for BRAF mutation. Negative status of BRAFV600E
mutation … By contrast, positive status of BRAFV600E mutation was a significant predictor of …

… further test the hypothesis that the BRAF V600E mutation is a prognostic indicator for PTC.
The study determined the prevalence of the BRAF V600E mutation in conventional PTC tissue …

… In patients with conventional papillary thyroid cancer, BRAF V600E mutation was associated
with older age (P = 0.0381), lymph node metastasis (P = 0.0323), distant metastasis (P = …

Purpose This study was designed to examine the aggressive features of BRAF-positive
papillary thyroid cancer (PTC) and association with age. Methods We compared the …

… from Dr C Nucera (Harvard Medical School, Boston, MA, USA), whose team established
this cell line from undifferentiated human thyroid carcinoma cells expressing the BRAF V600E …